128 related articles for article (PubMed ID: 3480288)
1. Type beta transforming growth factor (TGF beta) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cells.
Noda M; Rodan GA
J Cell Physiol; 1987 Dec; 133(3):426-37. PubMed ID: 3480288
[TBL] [Abstract][Full Text] [Related]
2. Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells.
Andrianarivo AG; Robinson JA; Mann KG; Tracy RP
J Cell Physiol; 1992 Nov; 153(2):256-65. PubMed ID: 1429847
[TBL] [Abstract][Full Text] [Related]
3. Effects of transforming growth factor-beta on osteoblastic osteosarcoma cells.
Pfeilschifter J; D'Souza SM; Mundy GR
Endocrinology; 1987 Jul; 121(1):212-8. PubMed ID: 3474142
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro.
Rosen DM; Stempien SA; Thompson AY; Seyedin SM
J Cell Physiol; 1988 Mar; 134(3):337-46. PubMed ID: 3162457
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone enhancement of betaglycan (TGF-beta type III receptor) gene expression in osteoblast-like cells.
Nakayama H; Ichikawa F; Andres JL; Massagué J; Noda M
Exp Cell Res; 1994 Apr; 211(2):301-6. PubMed ID: 8143777
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells.
Kwok S; Qin L; Partridge NC; Selvamurugan N
J Cell Biochem; 2005 Aug; 95(5):1002-11. PubMed ID: 15880704
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta modulates proliferation of osteoblastic cells: relation to its effect on receptor levels for epidermal growth factor.
Uneno S; Yamamoto I; Yamamuro T; Okumura H; Ohta S; Lee K; Kasai R; Konishi J
J Bone Miner Res; 1989 Apr; 4(2):165-71. PubMed ID: 2728921
[TBL] [Abstract][Full Text] [Related]
8. Role of albumin in osteoblastic cells: enhancement of cell proliferation and suppression of alkaline phosphatase activity.
Ishida K; Yamaguchi M
Int J Mol Med; 2004 Dec; 14(6):1077-81. PubMed ID: 15547677
[TBL] [Abstract][Full Text] [Related]
9. Effects of transforming growth factor-beta 1 on murine clonal osteoblastic cells (MC3T3-E1).
Okawa M; Hakeda Y; Wakatsuki N; Katoh Y; Higashino K; Kumegawa M
Meikai Daigaku Shigaku Zasshi; 1990; 19(3):310-22. PubMed ID: 2134892
[TBL] [Abstract][Full Text] [Related]
10. TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype.
Breen EC; Ignotz RA; McCabe L; Stein JL; Stein GS; Lian JB
J Cell Physiol; 1994 Aug; 160(2):323-35. PubMed ID: 8040190
[TBL] [Abstract][Full Text] [Related]
11. Effects of transforming growth factors beta 1 and beta 2 on a mouse clonal, osteoblastlike cell line MC3T3-E1.
Ibbotson KJ; Orcutt CM; Anglin AM; D'Souza SM
J Bone Miner Res; 1989 Feb; 4(1):37-45. PubMed ID: 2718777
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells.
Subramaniam M; Oursler MJ; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1995 Jan; 57(1):52-61. PubMed ID: 7721958
[TBL] [Abstract][Full Text] [Related]
13. Regulation of expression of the cell adhesion receptors, integrins, by recombinant human interleukin-1 beta in human osteosarcoma cells: inhibition of cell proliferation and stimulation of alkaline phosphatase activity.
Dedhar S
J Cell Physiol; 1989 Feb; 138(2):291-9. PubMed ID: 2521862
[TBL] [Abstract][Full Text] [Related]
14. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
Koutsilieris M; Reyes-Moreno C; Sourla A; Dimitriadou V; Choki I
Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
[TBL] [Abstract][Full Text] [Related]
15. Effects of orbital spaceflight on human osteoblastic cell physiology and gene expression.
Harris SA; Zhang M; Kidder LS; Evans GL; Spelsberg TC; Turner RT
Bone; 2000 Apr; 26(4):325-31. PubMed ID: 10719274
[TBL] [Abstract][Full Text] [Related]
16. beta-Cryptoxanthin stimulates cell proliferation and transcriptional activity in osteoblastic MC3T3-E1 cells.
Uchiyama S; Yamaguchi M
Int J Mol Med; 2005 Apr; 15(4):675-81. PubMed ID: 15754031
[TBL] [Abstract][Full Text] [Related]
17. Modulation of responses to TGF-beta by 1, 25 dihydroxyvitamin D3 in MG-63 osteoblastic cells: possible involvement of regulation of TGF-beta type II receptor.
Iimura T; Oida S; Ichijo H; Goseki M; Maruoka Y; Takeda K; Sasaki S
Biochem Biophys Res Commun; 1994 Oct; 204(2):918-23. PubMed ID: 7980561
[TBL] [Abstract][Full Text] [Related]
18. beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells.
Uchiyama S; Yamaguchi M
J Cell Biochem; 2005 Aug; 95(6):1224-34. PubMed ID: 15962303
[TBL] [Abstract][Full Text] [Related]
19. Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation.
Siggelkow H; Rebenstorff K; Kurre W; Niedhart C; Engel I; Schulz H; Atkinson MJ; Hüfner M
J Cell Biochem; 1999 Oct; 75(1):22-35. PubMed ID: 10462701
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of retinoic acid and growth factors on osteoblastic markers and CD10/NEP activity in stromal-derived osteoblasts.
Benayahu D; Fried A; Shamay A; Cunningham N; Blumberg S; Wientroub S
J Cell Biochem; 1994 Sep; 56(1):62-73. PubMed ID: 7528753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
